FERRARO, Giuseppa

FERRARO, Giuseppa  

Dipartimento di Patologia Umana dell'adulto e dell'età evolutiva "Gaetano Barresi"  

Mostra records
Risultati 1 - 20 di 51 (tempo di esecuzione: 0.027 secondi).
Titolo Data di pubblicazione Autore(i) File
A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): old successes and future perspectives 1-gen-2015 Russo, Alessandro; Franchina, Tindara; Ricciardi, Giuseppina Rosaria; Picone, Antonio; Ferraro, Giuseppa; Zanghì, Mariangela; Toscano, Giuseppe; Giordano, Antonio; Adamo, Vincenzo
A new method for titration of oral transmucosal fentanyl citrate (OTFC) starting dose in cancer patients. 1-gen-2006 Scandurra, G; Ferraro, Giuseppa; Franchina, Tindara; Chiofalo, G; Zanghi', Mariangela; Festa, V; Pastura, G; Adamo, Vincenzo
A PHASE II STUDY (21 DAY REGIMEN) OF GEMCITABINE AND CISPLATIN IN TRANSITIONAL CELL CARCINOMA OF BLADDER 1-gen-2001 Adamo, Vincenzo; Scimone, A.; DE VINCENZO, F.; D'Angelo, A.; Ferraro, Giuseppa; Altavilla, Giuseppe; Garipoli, Claudia; Zanghi', Mariangela
Androgen Receptor (AR), E-Cadherin, and Ki-67 as emerging targets and novel prognostic markers in triple-negative breast cancer (TNBC) patients 1-gen-2015 Ricciardi, GIUSEPPINA ROSARIA; Adamo, Barbara; Ieni, Antonio; Licata, Luana; Cardia, Roberta; Ferraro, Giuseppa; Franchina, Tindara; Tuccari, Giovanni; Adamo, Vincenzo
Androgen receptor (AR), E-cadherin, and Ki-67 as prognostic markers in triple-negative breast cancer (TNBC). 1-gen-2013 Ricciardi, GIUSEPPINA ROSARIA; Adamo, Barbara; Ferraro, Giuseppa; Franchina, Tindara; Zanghi', Mariangela; Buda, Carmelo; Trimarchi, Giuseppe; Cardia, R; Tuccari, Giovanni; Adamo, Vincenzo
Beta=interferon in the treatment of 14 patie nts with advanced colorectal carcinoma. J Exp Pathol. 1987 Summer;3(4):603-5. No abstract available. PMID: 3454807 [PubMed - indexed for MEDLINE] 1-gen-1987 Pitini, Vincenzo; Palmara, D; Ferraro, Giuseppa; Zanghi', Mariangela; LA TORRE, F; Tomasello, R; Chille, G.
Central nervous system involvement in ALK-rearranged NSCLC: promising strategies to overcome crizotinib resistance 1-gen-2016 Russo, Alessandro; Franchina, Tindara; Ricciardi, Giuseppina Rosaria Rita; Ferraro, Giuseppa; Scimone, Antonino; Bronte, Giuseppe; Russo, Antonio; Rolfo, Christian; Adamo, Vincenzo
Cigarette smoking habit does not reduce the benefit from first line trastuzumab-based treatment in advanced breast cancer patients 1-gen-2011 Daniele, Santini; Bruno, Vincenzi; Adamo, Vincenzo; Raffaele, Addeo; Vittorio, Fusco; Antonio, Russo; Filippo, Montemurro; Ilaria, Roato; Stefania, Redana; Gaetano, Lanzetta; MARIA ANTONIETTA, Satolli; Alfredo, Berruti; Valentina, Leoni; Sara, Galluzzo; Mauro, Antimi; Ferraro, Giuseppa; Maura, Rossi; SALVATORE DEL, Prete; MARIA ROSARIA, Valerio; Monica, Marra; Michele, Caraglia; Giuseppe, Tonini
Correction: Androgen Receptor (AR), E-cadherin, and Ki-67 as emerging targets and novel prognostic markers in Triple-Negative Breast Cancer (TNBC) patients 1-gen-2015 Ricciardi, Giuseppina Rosaria Rita; Adamo, Barbara; Ieni, Antonio; Licata, Luana; Cardia, Roberta; Ferraro, Giuseppa; Franchina, Tindara; Tuccari, Giovanni; Adamo, Vincenzo
Correlation between serum magnesium levels and skin toxicity during cetuximab treatment in squamous cell carcinoma of head and neck cancer (SCCHN): the role of weekly intravenous magnesium supplementation. 1-gen-2013 Ferraro, Giuseppa; Proto, C; Del Re, C; Agostino, R; Zanghi', Mariangela; Buda, Carmelo; Ricciardi, GIUSEPPINA ROSARIA; Adamo, Vincenzo
Current knowledge and future directions on bisphosphonate-related osteonecrosis of the jaw in cancer patients 1-gen-2008 Adamo, Vincenzo; Caristi, Nicola; MAUGERI SACCA', Marcello; Ferraro, Giuseppa; Arcana', Concetta; Maisano, R; Santini, D; Tonini, G.
Early Breast Cancer HER2 positivo in postmenopausa: strategia terapeutica adiuvante 1-gen-2010 Adamo, Vincenzo; Giusi, Ricciardi; Ferraro, Giuseppa
Effectiveness of the combination therapy with lisinopril, ivabradine and multivitamin supplementation in anthracycline-induced severe cardiotoxicity 1-gen-2014 DE GREGORIO, Cesare; Giuseppina, Potenza; Ferraro, Giuseppa
Efficacy of nab-paclitaxel plus trastuzumab in a long-surviving heavily pretreated HER2-positive breast cancer patient with brain metastases 1-gen-2015 Ricciardi, Giuseppina Rosaria Rita; Russo, Alessandro; Franchina, Tindara; Ferraro, Giuseppa; Adamo, Vincenzo
Epidermal growth factor receptor (EGFR) G719C mutation as new determinant of long term survival and response in patients with non small cell lung cancer treated with erlotinib: 1-gen-2011 Franchina, Tindara; Proto, C; Noto, L; Chiofalo, G; Ferraro, Giuseppa; Picciotto, Maria; Adamo, Vincenzo
Etoposide, l-leucovorin and fluorouracil (ELF) regimen in metastatic gastric cancer: A phase II study 1-gen-1999 Adamo, Vincenzo; Scimone, A; Maisano, R; Altavilla, Giuseppe; Ferraro, Giuseppa; Laudani, A; Pergolizzi, Stefano; Zanghi', Mariangela
Etoposide, l-leucovorin and fluorouracil (ELF) regimen in metastatic gastric cancer: a phase II study. J Chemother. 1999 Feb;11(1):74-7. PMID: 10078785 [PubMed - indexed for MEDLINE] 1-gen-1999 Adamo, Vincenzo; Scimone, A; Maisano, R; Altavilla, Giuseppe; Ferraro, Giuseppa; Laudani, A; Pergolizzi, Stefano; Zanghi', Mariangela
Gemcitabine (GEM) and cisplatin (CIS) in advanced/metastatic transitional cell carcinoma (TCC) of bladder:phase II study 1-gen-2000 Adamo, Vincenzo; A., D'Angelo; Ferraro, Giuseppa; Alafaci, Elisabetta; Altavilla, Giuseppe; Garipoli, Claudia; Magno, Carlo; A., Scimone; Zanghi', Mariangela
Impact of integrated treatments on patient management in solid tumors: from diagnosis to palliative care. 1-gen-2006 Adamo, Vincenzo; Ferraro, Giuseppa; Adamo, Barbara; Franchina, Tindara; Garipoli, Claudia
Incidence and preferential localizations of bone metastases: biomolecolar and clinical implications. 1-gen-2005 Adamo, Vincenzo; Ferraro, Giuseppa; Franchina, Tindara; Adamo, Barbara; Scimone, A.